2021 CMSC Annual Meeting

Tag: MD2

Poster-Symptom Management

Symptom Burden and Treatment Goals of People with MS Spasticity: Results from SEEN-MSS, a Large-Scale, Self-Reported Survey

Background: Evidence suggests that people with multiple sclerosis and spasticity (pwMSS) experience multiple concurrent symptoms that...

Read More

Poster-Symptom Management

The Effect of Hypnotics and Stimulants on Fatigue, Sleep, and Quality of Life Outcomes in a Multiple Sclerosis Cohort

Background: Sleep disturbance in persons with multiple sclerosis (pwMS) is associated with fatigue, depression, future cognitive decline,...

Read More

Poster-Relapse Therapy

Results from a Multicenter, Randomized, Double Blind, Placebo-Controlled Study of Repository Corticotropin Injection for Relapsing-Remitting Multiple Sclerosis

Background: Patients with relapsing-remitting multiple sclerosis (RRMS) may experience acute relapses that are nonresponsive (20-35%) to...

Read More

Poster-Quality of Life and Outcomes

Patient-Reported Outcome Measures in Multiple Sclerosis Clinical Trials: Critical Assessment and Insights from People Living with Multiple Sclerosis

Background: Multiple sclerosis (MS) clinical trials often include patient-reported outcomes (PROs) to quantify treatment effects not...

Read More

Poster-Quality of Life and Outcomes

Improving Communication about Multiple Sclerosis: The MS-Support Decision Aid

Background: Good communication between patients and their health care provider (HCP) is essential for shared decision making (SDM). We...

Read More

Poster-Quality of Life and Outcomes

Fatigue Evolution for Patients without Relapses on the Fsiq-RMS Symptoms Domain

Background: Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system that results in progressive and...

Read More

Poster-Quality of Life and Outcomes

Multiple Sclerosis: The Relationship of Cognitive Impairment and Self-Efficacy of Medication Management

Background: Multiple Sclerosis (MS) is a chronic disease for which there are multiple disease modifying therapies and symptomatic...

Read More

Poster-Programs

The Multiple Sclerosis at Home Access Program (MAHA): New Challenges for Those Living with Multiple Sclerosis and Significant Disability during the COVID-19 Pandemic

Background: Abundant evidence supports disparity in health care delivery for persons with disability. These disparities may be magnified...

Read More

Poster-Neuroimmunology and disease models

Mucosal Associated Invariant T (MAIT) Cells Show Defective Activation in People with Multiple Sclerosis

Background: mucosal associated invariant T (MAIT) cells are innate-like T cells expressing an invariant TCR ? chain with a limited number...

Read More

Poster-Non-imaging Biomarkers

Cerebrospinal Fluid Protein Is Higher in Males with Multiple Sclerosis: Results from an International Multicenter Cohort

Background: Sex has a differential effect on MS disease severity. Males tend to have a more severe clinical course and a greater tendency...

Read More